Aminoacyl‐tRNA synthetases (AARSs) define genetic code by pairing amino acids with their cognate tRNAs and maintain ‘quality control’ in the flow of information from gene to protein. Binding energies of amino acids to AARSs are often inadequate to assure the required accuracy of translation. This has necessitated the evolution of a second determinant of specificity, proofreading or editing mechanisms that remove amino acid selection errors, thereby maintaining accuracy and preventing access to the genetic code of non‐protein amino acids, including homocysteine, ornithine, homoserine and norvaline. Editing is part of the tRNA aminoacylation process in living organisms from bacteria to humans. Impaired amino acid editing reduces cell proliferation under stress conditions and can lead to disease. Despite a strong selective pressure to minimise mistranslation, some organisms possess error‐prone AARSs that cause mistranslation, which can be beneficial for pathogens by increasing their phenotypic variation essential for the evasion of host defences.
Key Concepts
Aminoacyl‐tRNA synthetases match tRNAs with corresponding amino acids, thereby translating genetic information from the nucleic acid to the protein language.
Faithful translation of the genetic information depends on editing of amino acid misactivation errors.
Editing occurs at the synthetic active site by hydrolysis of aminoacyl‐adenylates (
pre‐transfer
editing) and/or at a separate editing site by deacylation of aminoacyl‐tRNA (
post‐transfer
editing).
Access of the non‐protein amino acids, such as homocysteine, ornithine or norvaline to the genetic code is prevented by editing.
Preventing mistranslation by editing of misactivated amino acids is crucial to cellular homeostasis.
Impaired editing increases sensitivity of cells to oxidative stress and nutritional imbalance.
Some pathogenic organisms possess editing‐defective, error‐prone AARSs that cause mistranslation, which is essential for the evasion of host defences.
Synthetic biology targets AARSs to engineer new proteins containing non‐canonical amino acids (alloproteins).